Perioperative heparinase rotational thromboelastometry monitoring in adult living related liver transplantation.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201712002839259

Enrollment

Registered

2017-12-05

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System End-stage liver disease for scheduled liver transplantation

Interventions

Hypercoagulable

Non Hypercoagulable

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All adult patients with end stage liver disease scheduled for live adult liver transplantation were enrolled within a 2 year study period.

Exclusion criteria

Exclusion criteria: Any factor that interfere with coagulation such as patient on oral anticoagulant, or on procoagulant as activated factor seven (Novoseven).

Design outcomes

Primary

Measure	Time frame
Clotting Time (CT) of heparinase ROTAM;Maximal Clot Firmness (MCF) of heparinase ROTAM	—

Secondary

Measure	Time frame
Post-operative heparin infusion effect on ROTAM and standard coagulation tests	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026